Interstitial Lung Disease Global Market Report 2024

Description

“Interstitial Lung Disease Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interstitial lung disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interstitial lung disease? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The interstitial lung disease market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Drug Type: Oral Corticosteroids; Immune Suppressing; Anti-Fibrotic Medication; Other Drugs
2) By Disease Type: Interstitial Pneumonia; Idiopathic Pulmonary Fibrosis; Nonspecific Interstitial Pneumonitis; Hypersensitivity Pneumonitis; Cryptogenic Organizing Pneumonia (COP); Sarcoidosis; Acute Interstitial Pneumonitis
3) By Application: Adults; Children
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Roche Laboratories Inc.; Merck & Co. Inc.; Bayer AG; Novartis Pharmaceuticals Corporation; The Bristol-Myers Squibb Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Interstitial lung disease (ILD) refers to a group of lung conditions that affect the interstitium, the tissue and space surrounding the alveoli in the lungs. The interstitium is crucial for maintaining the structural integrity and function of the lungs, facilitating the exchange of gases between the lungs and the bloodstream.

The primary types of drugs used in the treatment of interstitial lung disease include oral corticosteroids, immunosuppressive medications, anti-fibrotic drugs, and others. Interstitial pneumonia, also referred to as non-infectious interstitial pneumonia, is a specific type of interstitial lung disease (ILD) that affects the interstitium, the tissue supporting the air sacs (alveoli) in the lungs. These drugs are indicated for the treatment of various ILD conditions, including interstitial pneumonia, idiopathic pulmonary fibrosis, nonspecific interstitial pneumonitis, hypersensitivity pneumonitis, cryptogenic organizing pneumonia (COP), sarcoidosis, and acute interstitial pneumonitis in both adults and children. They are distributed through a range of channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The interstitial lung disease market research report is one of a series of new reports from The Business Research Company that provides interstitial lung disease market statistics, including interstitial lung disease industry global market size, regional shares, competitors with an interstitial lung disease market share, detailed interstitial lung disease market segments, market trends and opportunities and any further data you may need to thrive in the interstitial lung disease industry. This interstitial lung disease market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The interstitial lung disease market size has grown strongly in recent years. It will grow from $1.83 billion in 2023 to $1.97 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to awareness and diagnosis improvement, immune system modulation therapies, respiratory rehabilitation programs, multidisciplinary care teams.

The interstitial lung disease market size is expected to see strong growth in the next few years. It will grow to $2.62 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to precision medicine, novel drug development, regenerative medicine, telehealth and remote monitoring. Major trends in the forecast period include advancements in imaging technology, ai in imaging, fibrosis subtype differentiation, supportive care services.

The expansion in the prevalence of allergic conditions is anticipated to be a driving force behind the growth of the interstitial lung disease market in the future. Allergic conditions occur when the immune system reacts excessively to allergens, often harmless substances. These allergic reactions can lead to interstitial lung disease (ILD), specifically hypersensitivity pneumonitis, which is triggered by an allergic response within the body. For instance, as of January 2023, the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, reported that in 2021, over one-third of American adults and more than one-fourth of American children experienced seasonal allergies, eczema, or food allergies. Additionally, severe allergic reactions to food, known as anaphylaxis, were estimated to result in 90,000 emergency room visits in the United States annually. Hence, the growing prevalence of allergic conditions is a significant driver of the interstitial lung disease market's growth.

The increasing incidence of autoimmune ailments is set to propel the expansion of the interstitial lung disease market in the foreseeable future. Autoimmune ailments refer to medical conditions where the immune system mistakenly targets the body's healthy tissues and cells. The rise in autoimmune ailment cases plays a crucial role in the interstitial lung disease market by augmenting the demand for healthcare services related to ILD, spurring research and development initiatives, and fostering advancements in treatments and patient care. For instance, in September 2023, the Institute for Health Metrics and Evaluation, a US-based global health research center, projected that the global cases of rheumatoid arthritis would increase from around 17.6 million in 2020 to approximately 31.7 million by 2050. This substantial rise in cases over the coming decades underscores the growing incidence of autoimmune ailments. Consequently, the increasing prevalence of autoimmune ailments is a key driver of the interstitial lung disease market's growth.

The growth of the interstitial lung disease market is hindered by delayed diagnoses during the forecast period. Delayed diagnosis of interstitial lung disease (ILD) poses significant challenges to patients as it raises the risk of complications and has psychosocial impacts, ultimately leading to increased healthcare costs. For example, in 2021, the British Thoracic Society, a UK-based charitable organization, reported substantial delays between the onset of ILD symptoms and the actual diagnosis, with approximately 40% of patients enduring waiting periods exceeding two years before receiving a formal diagnosis. Consequently, delayed diagnosis has impeded the progress of the interstitial lung disease market.

Major companies operating in the interstitial lung disease market are committed to developing innovative drugs to provide effective treatment options and maintain their market standing. The development of new drugs holds the potential to improve treatment outcomes for patients with lung-related conditions. For instance, in April 2021, United Therapeutics, a US-based biotechnology company, introduced Tyvaso, a medication designed to enhance exercise capacity in patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3). Tyvaso is a sterile form of the prostacyclin-mimicking drug treprostinil, specifically designed for oral inhalation using the Tyvaso inhalation system.

In June 2023, Merck & Co., a US-based pharmaceutical company, acquired Prometheus Biosciences Inc. for $10.3 billion. This strategic acquisition is aimed at strengthening Merck & Co.'s immunology drug pipeline as it faces the looming loss of exclusivity for some of its top-selling products in the coming years. Prometheus Biosciences Inc., a US-based biotechnology company, specializes in developing therapeutic and complementary diagnostic products for the management of immune-mediated disorders, including interstitial lung disease (ILD) associated with systemic sclerosis (SSc-ILD).

Major players in the interstitial lung disease market are Roche Laboratories Inc., Merck & Co. Inc., Bayer AG, Novartis Pharmaceuticals Corporation, The Bristol-Myers Squibb Company, Amgen Inc., Boehringer Ingelheim, Siemens Healthineers, Koninklijke Philips N.V., Teva Pharmaceuticals USA Inc., AstraZeneca PLC, Horizon Pharma USA Inc., Genentech Inc., Amneal Pharmaceuticals LLC, Fujirebio Diagnostics Inc., Insmed Inc., VIDA Diagnostics Inc., EmphyCorp Inc., Verseau Therapeutics, Regend Therapeutics Co., LTT Bio-Pharma Co. Ltd., Galecto Biotech, Pulmatrix Inc., PureTech Health PLC, Pneuma Respiratory Inc., Bellerophon Therapeutics Inc., MediciNova Inc., Altavant Sciences Inc., Verona Pharma plc .

North America was the largest region in the interstitial lung disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interstitial lung disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the interstitial lung disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The interstitial lung disease market consists of revenues earned by entities by providing services such as individualized treatment plans and comprehensive support, pulmonary rehabilitation and oxygen therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The interstitial lung disease market also includes sales of prednisone, mycophenolate, azathioprine and cyclophosphamide. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12365

1. Executive Summary

2. Interstitial Lung Disease Market Characteristics

3. Interstitial Lung Disease Market Trends And Strategies

4. Interstitial Lung Disease Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Interstitial Lung Disease Market Size and Growth

5.1. Global Interstitial Lung Disease Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Interstitial Lung Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Interstitial Lung Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Interstitial Lung Disease Market Segmentation

6.1. Global Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral Corticosteroids
Immune Suppressing
Anti-Fibrotic Medication
Other Drugs
6.2. Global Interstitial Lung Disease Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Interstitial Pneumonia
Idiopathic Pulmonary Fibrosis
Nonspecific Interstitial Pneumonitis
Hypersensitivity Pneumonitis
Cryptogenic Organizing Pneumonia (COP)
Sarcoidosis
Acute Interstitial Pneumonitis
6.3. Global Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Adults
Children
6.4. Global Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

7. Interstitial Lung Disease Market Regional And Country Analysis

7.1. Global Interstitial Lung Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Interstitial Lung Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Interstitial Lung Disease Market

8.1. Asia-Pacific Interstitial Lung Disease Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Interstitial Lung Disease Market

9.1. China Interstitial Lung Disease Market Overview
9.2. China Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Interstitial Lung Disease Market

10.1. India Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Interstitial Lung Disease Market

11.1. Japan Interstitial Lung Disease Market Overview
11.2. Japan Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Interstitial Lung Disease Market

12.1. Australia Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Interstitial Lung Disease Market

13.1. Indonesia Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Interstitial Lung Disease Market

14.1. South Korea Interstitial Lung Disease Market Overview
14.2. South Korea Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Interstitial Lung Disease Market

15.1. Western Europe Interstitial Lung Disease Market Overview
15.2. Western Europe Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Interstitial Lung Disease Market

16.1. UK Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Interstitial Lung Disease Market

17.1. Germany Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Interstitial Lung Disease Market

18.1. France Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Interstitial Lung Disease Market

19.1. Italy Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Interstitial Lung Disease Market

20.1. Spain Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Interstitial Lung Disease Market

21.1. Eastern Europe Interstitial Lung Disease Market Overview
21.2. Eastern Europe Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Interstitial Lung Disease Market

22.1. Russia Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Interstitial Lung Disease Market

23.1. North America Interstitial Lung Disease Market Overview
23.2. North America Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Interstitial Lung Disease Market

24.1. USA Interstitial Lung Disease Market Overview
24.2. USA Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Interstitial Lung Disease Market

25.1. Canada Interstitial Lung Disease Market Overview
25.2. Canada Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Interstitial Lung Disease Market

26.1. South America Interstitial Lung Disease Market Overview
26.2. South America Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Interstitial Lung Disease Market

27.1. Brazil Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Interstitial Lung Disease Market

28.1. Middle East Interstitial Lung Disease Market Overview
28.2. Middle East Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Interstitial Lung Disease Market

29.1. Africa Interstitial Lung Disease Market Overview
29.2. Africa Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Interstitial Lung Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Interstitial Lung Disease Market Competitive Landscape And Company Profiles

30.1. Interstitial Lung Disease Market Competitive Landscape
30.2. Interstitial Lung Disease Market Company Profiles
- 30.2.1. Roche Laboratories Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck & Co. Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Bayer AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Novartis Pharmaceuticals Corporation
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. The Bristol-Myers Squibb Company
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Interstitial Lung Disease Market Other Major And Innovative Companies

31.1. Amgen Inc.
31.2. Boehringer Ingelheim
31.3. Siemens Healthineers
31.4. Koninklijke Philips N.V.
31.5. Teva Pharmaceuticals USA Inc.
31.6. AstraZeneca plc
31.7. Horizon Pharma USA Inc.
31.8. Genentech Inc.
31.9. Amneal Pharmaceuticals LLC
31.10. Fujirebio Diagnostics Inc.
31.11. Insmed Inc.
31.12. VIDA Diagnostics Inc.
31.13. EmphyCorp Inc.
31.14. Verseau Therapeutics
31.15. Regend Therapeutics Co.

32. Global Interstitial Lung Disease Market Competitive Benchmarking

33. Global Interstitial Lung Disease Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Interstitial Lung Disease Market

35. Interstitial Lung Disease Market Future Outlook and Potential Analysis

35.1 Interstitial Lung Disease Market In 2028 - Countries Offering Most New Opportunities
35.2 Interstitial Lung Disease Market In 2028 - Segments Offering Most New Opportunities
35.3 Interstitial Lung Disease Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer